<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-199-3-15-25</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-1938</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Патология пародонта у пациентов с циррозами печени</article-title><trans-title-group xml:lang="en"><trans-title>Periodontal pathology in patients with cirrhosis of the liver</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0457-3303</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Еремин Андрей Вячеславович - ректор, кандидат медицинских наук, доцент кафедры ортопедической стоматологии, ResearcherID: AAJ-6804–2021.</p><p>410012, Саратов, Большая Казачья ул.,112</p></bio><bio xml:lang="en"><p>Andrey V. Eremin - Rector, Candidate of Medical Sciences, Associate Professor of Department of Orthopedic Stomatology; ResearcherID: AAJ-6804–2021.</p><p>Bol’shaya Kazach’ya str., Saratov, 410012</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Савина Екатерина Александровна - кандидат медицинских наук, доцент пропедевтики стоматологических заболеваний. ResearcherID: AAJ-7791–2021.</p><p>410012, Саратов, Большая Казачья ул.,112</p></bio><bio xml:lang="en"><p>Ekaterina A. Savina - Candidate of Medical Sciences, Associate Professor of Department of Propaedeutics of Dental Diseases; ResearcherID: AAJ-7791–2021.</p><p>Bol’shaya Kazach’ya str., Saratov, 410012</p></bio><email xlink:type="simple">ekaterinasavina87@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1711-0893</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремин</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremin</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Еремин Олег Вячеславович - доктор медицинских наук, доцент, заведующий кафедрой пропедевтики стоматологических заболеваний.</p><p>410012, Саратов, Большая Казачья ул.,112</p></bio><bio xml:lang="en"><p>Oleg V. Eremin - MD, DSc, Head of Department of Propaedeutics of Dental Diseases.</p><p>Bol’shaya Kazach’ya str., Saratov, 410012</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Саратовский государственный медицинский университет им. В.И. Разумовского МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov State Medical University n. a. V.I. Razumovsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>04</day><month>10</month><year>2022</year></pub-date><volume>0</volume><issue>3</issue><fpage>15</fpage><lpage>25</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Еремин А.В., Савина Е.А., Еремин О.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Еремин А.В., Савина Е.А., Еремин О.В.</copyright-holder><copyright-holder xml:lang="en">Eremin A.V., Savina E.A., Eremin O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/1938">https://www.nogr.org/jour/article/view/1938</self-uri><abstract><p>Исследованы частота и клиническое течение хронического генерализованного пародонтита на фоне циррозов печени различной этиологии. Обследованы 70 пациентов с хроническим генерализованным пародонтитом различной степени в сочетании с циррозами печени (у 23 пациентов (32,9%) выявлен цирроз печени класс А, 25 (35,7%) — класс В, 22 (31,4%) — класс С. Группа сравнения — 17 пациентов с пародонтитом без соматической патологии. Контрольная группа — 20 практически здоровых добровольцев. Выявлено значимо сниженный уровень гигиены полости рта у пациентов с циррозами печени классов В и С. В содержимом пародонтальных карманов при ЦП достоверно чаще встречались пародонтопатогенные микроорганизмы. С увеличением класса ЦП повышалась частота бактериальной экспансии. Тяжесть поражения пародонта у пациентов с циррозами печени связана с потерей минеральной плотности кости по типу остеопении (47,2%) или остеопороза (31,4%), нарастающего соответственно классу цирроза печени и тяжести заболевания пародонта. Степень резорбции альвеолярного отростка связана с системным снижением минеральной плотности костной ткани. Наиболее тяжелые проявления генерализованного остеопенического синдрома и резорбции альвеолярных отростков характерны для пациентов с алкогольным поражением печени и циррозом печени с синдромом холестаза.</p></abstract><trans-abstract xml:lang="en"><p>The frequency and clinical course of chronic generalized periodontitis against the background of liver cirrhosis of various etiologies were studied. 70 patients with chronic generalized periodontitis of varying degrees in combination with liver cirrhosis were examined (23 patients (32.9%) had liver cirrhosis class A, 25 (35.7%) — class B, 22 (31.4%) — class C. Comparison group — 17 patients with periodontitis without somatic pathology. Control group — 20 practically healthy volunteers. A signiﬁ cantly reduced level of oral hygiene was revealed in patients with liver cirrhosis of classes B and C. Periodontal pathogenic microorganisms were signiﬁ cantly more common in the contents of periodontal pockets with cirrhosis. With an increase in the class of CP, the frequency of bacterial expansion increased. The severity of periodontal damage in patients with liver cirrhosis is associated with a loss of bone mineral density by the type of osteopenia (47.2%) or osteoporosis (31.4%), increasing according to the class of liver cirrhosis and the severity of periodontal disease The degree of resorption of the alveolar process is associated with a systemic decrease in bone mineral density. The eﬀ ects of generalized osteopenic syndrome and resorption of the alveolar processes are characteristic of patients with alcoholic liver damage and liver cirrhosis with cholestasis syndrome.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цирроз печени</kwd><kwd>воспалительные заболевания пародонта</kwd><kwd>вирусный гепатит</kwd><kwd>холестаз</kwd><kwd>пародонтит</kwd><kwd>остеопенический синдром</kwd><kwd>печеночная энцефалопатия</kwd><kwd>алкогольный цирроз печени</kwd></kwd-group><kwd-group xml:lang="en"><kwd>liver cirrhosis</kwd><kwd>inﬂ ammatory periodontal disease</kwd><kwd>viral hepatitis</kwd><kwd>cholestasis</kwd><kwd>periodontitis</kwd><kwd>osteopenic syndrome</kwd><kwd>hepatic encephalopathy</kwd><kwd>alcoholic cirrhosis of the liver</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Vaz J., Eriksson B., Strömberg U., et al. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-b ased cohort study. BMC Gastroenterol, 2020;20(1):84. Published 2020 Apr 3. doi:10.1186/s12876–020–01239–6</mixed-citation><mixed-citation xml:lang="en">Vaz J., Eriksson B., Strömberg U., et al. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-b ased cohort study. BMC Gastroenterol, 2020;20(1):84. Published 2020 Apr 3. doi:10.1186/s12876–020–01239–6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В. Т., Маевская М. В., Павлов Ч. С., и др. Клинические рекомендации Россий ского общества по изучению печении Россий ской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Рос журн гастроэнтерол гепатол колопроктол, 2016;26(4):71–102.</mixed-citation><mixed-citation xml:lang="en">Ivashkin V. T., Mayevskaya M. V., Pavlov Ch.S., Fedosyina Ye.A., et al. Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientifi c Liver Society and Russian gastroenterological association. Ross z gastroenterol gepatol koloproktol, 2016; 26(4):71–102. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Melato M., Sasso F., Zanconati F. Liver cirrhosis and liver cancer. A study of their relationship in 2563 autopsies. Zentralbl Pathol. 1993; 139(1): 25–30. PMID: 8388716.</mixed-citation><mixed-citation xml:lang="en">Melato M., Sasso F., Zanconati F. Liver cirrhosis and liver cancer. A study of their relationship in 2563 autopsies. Zentralbl Pathol. 1993; 139(1): 25–30. PMID: 8388716.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Grauda N., Leth P., Marbjerg L., Galloe A. M. Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases of cirrhosis, detected in 4929 consecutive autopsies. J Intern Med, 1991; 230:165–171</mixed-citation><mixed-citation xml:lang="en">Grauda N., Leth P., Marbjerg L., Galloe A. M. Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases of cirrhosis, detected in 4929 consecutive autopsies. J Intern Med, 1991; 230:165–171</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lim Y. S., Kim W. R. Th e global impact of hepatic fi brosis and end-stage liver disease. Clin Liver Dis, 2008; 12 (4): 733–746. doi: 10.1016/j.cld.2008.07.007</mixed-citation><mixed-citation xml:lang="en">Lim Y. S., Kim W. R. Th e global impact of hepatic fi brosis and end-stage liver disease. Clin Liver Dis, 2008; 12 (4): 733–746. doi: 10.1016/j.cld.2008.07.007</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Шифф ЮР., Соррел МФ, Мэддрей УС. Болезни печени по Шиффу. Цирроз печени и его осложнения. Трансплантация печени –Москва: ГЭОТАР- Медиа, 2012. – 592с.</mixed-citation><mixed-citation xml:lang="en">SHiff  YU.R., Sorrel M. F., Meddrej U. S. [Diseases of the liver according to Schiff . Cirrhosis of the liver and its complications. Liver transplant]. Moscow. GEOTAR-Media Publ., 2012. 592p. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">EASL. Clinical Practice Guidelines: management of Hepatitis C virus infection. J. of Hepatology, 2011; 55:245–264. doi: 10.1016/j.jhep.2011.02.023</mixed-citation><mixed-citation xml:lang="en">EASL. Clinical Practice Guidelines: management of Hepatitis C virus infection. J. of Hepatology, 2011; 55:245–264. doi: 10.1016/j.jhep.2011.02.023</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">EASL. Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal Of Hepatology, 2018; 69: 406–460. PMID: 29653741. doi: 10.1016/j.jhep.2018.03.024</mixed-citation><mixed-citation xml:lang="en">EASL. Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal Of Hepatology, 2018; 69: 406–460. PMID: 29653741. doi: 10.1016/j.jhep.2018.03.024</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bajaj J. S. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol, 2008; 2:785–790. PMID: 19090738. doi: 10.1586/17474124.2.6.785</mixed-citation><mixed-citation xml:lang="en">Bajaj J. S. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol, 2008; 2:785–790. PMID: 19090738. doi: 10.1586/17474124.2.6.785</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan P. W., Rossetti A. O. EEG patterns and imaging correlations in encephalopathy: encephalopathy part II. J Clin Neurophysiol, 2011; 28:233–251. PMID: 21633250. doi: 10.1097/WNP.0b013e31821c33a0</mixed-citation><mixed-citation xml:lang="en">Kaplan P. W., Rossetti A. O. EEG patterns and imaging correlations in encephalopathy: encephalopathy part II. J Clin Neurophysiol, 2011; 28:233–251. PMID: 21633250. doi: 10.1097/WNP.0b013e31821c33a0</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kuang- Ting Yeh, Tzai- Chiu Yu, Ru- Ping Lee, et al. Hepatic encephalopathy increases the risk of hip fracture: a nationwide cohort study. BMC Musculoskeletal Disorders, 2020; 21:779. doi:10.1186/s12891–020–03811–3</mixed-citation><mixed-citation xml:lang="en">Kuang- Ting Yeh, Tzai- Chiu Yu, Ru- Ping Lee, et al. Hepatic encephalopathy increases the risk of hip fracture: a nationwide cohort study. BMC Musculoskeletal Disorders, 2020; 21:779. doi:10.1186/s12891–020–03811–3</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rehm J., Taylor B., Mohapatra S., et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev, 2010; 29(4): 437–445. doi: 10.1111/j.1465–3362.2009.00153</mixed-citation><mixed-citation xml:lang="en">Rehm J., Taylor B., Mohapatra S., et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev, 2010; 29(4): 437–445. doi: 10.1111/j.1465–3362.2009.00153</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">EASL. Clinical Practice Guidelines on the management of hepatitis B virus infection. J. of Hepatology, 2017;67(2):370–398. doi:10.1016/j.jhep.2017.03.021</mixed-citation><mixed-citation xml:lang="en">EASL. Clinical Practice Guidelines on the management of hepatitis B virus infection. J. of Hepatology, 2017;67(2):370–398. doi:10.1016/j.jhep.2017.03.021</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В. Т., Маевская М. В., Павлов Ч. С., и др. Клинические рекомендации Российского общества по изучению печени по ведению взрослых пациентов с алкогольной болезнью печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2017; 27(6): 20–40. doi: 10.22416/1382–4376–2017–27–6–20–40</mixed-citation><mixed-citation xml:lang="en">Ivashkin V. T., Mayevskaya M. V., Pavlov C. S., et al. Management of adult patients with alcoholic liver disease: clinical guidelines of the Russian Scientifi c Liver Society. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(6):20–40. (In Russ.) doi:10.22416/1382–4376–2017–27–6–20–40</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Beuers U., Trauner M., Jansen P., Poupon R. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol. 2015; 62:25– 37. PMID: 25920087. doi: 10.1016/j.jhep.2015.02.023</mixed-citation><mixed-citation xml:lang="en">Beuers U., Trauner M., Jansen P., Poupon R. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol. 2015; 62:25– 37. PMID: 25920087. doi: 10.1016/j.jhep.2015.02.023</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Полунина Т. Е. Холестатические заболевания печени: алгоритмы диагностики и лечения. РМЖ, 2021; 6:81–87.</mixed-citation><mixed-citation xml:lang="en">Polunina T. E. Cholestatic liver diseases: diagnostic and treatment algorithms. RMJ. 2021;6:81–87. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">EASL. Clinical Practical Guidelines: Management of Alcoholic Liver Disease. J. Hepatol, 2018; 69:154–181. PMID: 29628280. doi: 10.1016/j.jhep.2018.03.018</mixed-citation><mixed-citation xml:lang="en">EASL. Clinical Practical Guidelines: Management of Alcoholic Liver Disease. J. Hepatol, 2018; 69:154–181. PMID: 29628280. doi: 10.1016/j.jhep.2018.03.018</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Костюкевич О. И. Алкогольный гепатит: современные алгоритмы диагностики и лечения. РМЖ, 2016; 3: 177–182.</mixed-citation><mixed-citation xml:lang="en">Kostyukevich O. I. Alcoholic hepatitis: modern algorithms for diagnosis and treatment. RMJ, 2016; 3: 177–182 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Simplifi ed HCV Treatment Algorithm for Treatment- Naive Adults With Compensated Cirrhosis. Updated: September 29, 2021 © 2021 American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. Available at: https://www.hcvguidelines.org/sites/default/files/full-guidance-pdf/AASLDIDSA_HCV-Guidance_TxN-Simplified-Tx- Comp-Cirr_e.pdf Assessed: 09.11.2021.</mixed-citation><mixed-citation xml:lang="en">Simplifi ed HCV Treatment Algorithm for Treatment- Naive Adults With Compensated Cirrhosis. Updated: September 29, 2021 © 2021 American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. Available at: https://www.hcvguidelines.org/sites/default/files/full-guidance-pdf/AASLDIDSA_HCV-Guidance_TxN-Simplified-Tx-Comp- Cirr_e.pdf Assessed: 09.11.2021.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">EASL. Clinical Practice Guidelines. Recommendation on treatment of hepatitis C. Journal Of Hepatology, 2018; 69:461–511. PMID: 29650333. doi: 10.1016/j.jhep.2018.03.026</mixed-citation><mixed-citation xml:lang="en">EASL. Clinical Practice Guidelines. Recommendation on treatment of hepatitis C. Journal Of Hepatology, 2018; 69:461–511. PMID: 29650333. doi: 10.1016/j.jhep.2018.03.026</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Протоколы лечения (клинические рекомендации) при диагнозе пародонтит. URL: https://minzdrav.gov-murman.ru/documents/poryadki-okazaniyameditsinskoy-pomoshchi/8_parodontit.pdf (дата обращения 13.12.2021)</mixed-citation><mixed-citation xml:lang="en">Treatment protocols (clinical guidelines) for the diagnosis of periodontitis. Available at: https://minzdrav. gov-murman.ru/documents/poryadki-o kazaniyameditsinskoy- pomoshchi/8_parodontit.pdf Access: 13 December 2021. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Еремин О. В., Лепилин А. В., Еремин А. В. Подходы к протезированию дефектов зубных у пациентов с хроническими диффузными болезнями печени. Российский стоматологический журнал, 2012; 4: 26–29.</mixed-citation><mixed-citation xml:lang="en">Eremin O. V., Lepilin A. V., Eremin A. V. Features of prosthetics of dentition defects in patients with chronic diseases of the colon. Russian Dental Journal, 2012; 4: 26–29. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Staufer K., Yegles M. Biomarkers for detection of alcohol consumption in liver transplantation. World J Gastroenterol, 2016; 22(14):3725–3734. doi: 10.3748/wjg.v22.i14.3725</mixed-citation><mixed-citation xml:lang="en">Staufer K., Yegles M. Biomarkers for detection of alcohol consumption in liver transplantation. World J Gastroenterol, 2016; 22(14):3725–3734. doi: 10.3748/wjg.v22.i14.3725</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Прашнова МК. Райхельсон КЛ, Борисов АА. Костный метаболизм, минеральная плотность костной ткани и абсолютный риск костных переломов при аутоиммунных заболеваниях печени. Доктор. Ру. Гастроэнтерология. Часть I, 2015; 2(103): 29–33.</mixed-citation><mixed-citation xml:lang="en">Prashnova MK. Rajhel’son KL, Borisov AA. [Bone Metabolism, Bone Mineral Density, and Absolute Risk of Bone Fractures in Autoimmune Liver Disease]. Doktor. Ru Gastroenterology. Part I, 2015; 2(103): 29–33. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Santos LA.A, Romeiro F. G. Diagnosis and Management of Cirrhosis- Related Osteoporosis. Biomed Res Int, 2016; 1423462. doi: 10.1155/2016/1423462</mixed-citation><mixed-citation xml:lang="en">Santos LA.A, Romeiro F. G. Diagnosis and Management of Cirrhosis- Related Osteoporosis. Biomed Res Int, 2016; 1423462. doi: 10.1155/2016/1423462</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Еремин А. В., Лепилин А. В., Еремин О. В. Подходы к протезированию дефектов зубных рядов у пациентов с хроническими диффузными болезнями печени. Российский стоматологический журнал, 2012; 4: 26–29.</mixed-citation><mixed-citation xml:lang="en">Eremin A. V., Eremin O. V., Lepilin A. V. Approaches to prosthetics of dentition defects in patients with chronic diff use liver diseases. Russian Dental Journal, 2012; 4:26–29. (in Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
